Project Grant R01HL185055
Award Date 7/8/26
Completion Date 4/30/31
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $694,252 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for June 30, 2030. The award funds research into the mechanisms of cardioprotective Y RNA (YRNA) signaling in macrophages to enhance therapeutic outcomes following myocardial infarction. The research focuses on understanding how a...
- Federal Grant Award Summary Award Details: Cedars-Sinai Medical Center received a $1,214,851 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 20, 2025, with completion targeted for May 31, 2029. Research Scope and Deliverables: The grant funds investigation of nuclear transport mechanisms for SMAD signaling proteins, which are critical developmental effectors in left-right axis formation...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Cedars-Sinai Medical Center a Project Grant totaling $497,998 beginning September 1, 2025, and concluding August 31, 2028, under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds basic research investigating the nature and regulation of extramedullary hematopoiesis (EMH) in the liver, with focus on understanding how hematopoietic stem cells (HSCs) initiate blood cell production...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $717,680 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with completion targeted for March 31, 2029. The grant funds research to elucidate the immune epithelial niche underlying post-viral lung fibrosis, specifically investigating how persistent pulmonary fibrosis develops following severe viral respiratory...
- Project Grant Award Summary Cedars-Sinai Medical Center received a $740.5K Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 6, 2026, with completion targeted for March 31, 2030. The project focuses on advancing single-cell proteomics (SCP) technology to characterize protein heterogeneity in cardiomyocytes (CMs) affected by hypertrophic cardiomyopathy (HCM) mutations associated with the myosin...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $256,650 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 2, 2026, with a completion date of June 30, 2028. The project, titled "ISG15 Monocytes as Precursors to SPP1 Macrophages in Scleroderma ILD," will deliver mechanistic research and biomarker discovery services focused on...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $757,555 Project Grant award dated September 5, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate advanced magnetic resonance imaging (MRI) technology for quantifying iron content in hemorrhagic myocardial infarction (HMI) hearts. The project, which extends through June 30, 2029, addresses a critical clinical need by creating a...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $811,885 to the J. David Gladstone Institutes under the Cardiovascular Diseases Research program (CFDA 93.837) on September 12, 2025. The award funds research to elucidate epigenomic mechanisms of cardiac fibrosis and heart failure pathogenesis, with a completion date of May 31, 2029. The research leverages novel genetic mouse models, advanced transcriptional and epigenomic...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Massachusetts General Hospital a $739,474 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on August 18, 2025, to investigate the anti-fibrotic roles of stress-induced tRNA-derived small RNAs (tDRs) in cardiac fibrosis. The research will be conducted through May 31, 2030, and focuses on characterizing the mechanisms by which ASP-GTC-3' tDR, a regulatory RNA fragment derived from transfer RNA,...
- Federal Grant Award Summary Yale University received a $1.498 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 23, 2025, with a completion date of August 31, 2027. The award funds research investigating the molecular mechanisms of sex differences in scleroderma-associated interstitial lung disease (SSc-ILD), specifically examining the role of mitochondrial DNA (mtDNA) and Toll-like...